Literature DB >> 6093767

The effect of low-density lipoproteins on the synthesis of cyclic nucleotides induced by prostacyclin in isolated platelets.

K R Bruckdorfer, S Buckley, D G Hassall.   

Abstract

Isolated platelets are strongly sensitized by the presence of low-density lipoproteins (LDL) so that they aggregate with very low concentrations of other agonists or exhibit spontaneous aggregation. Prostacyclin (PGI2) is a potent inhibitor of aggregation, but its action was reversed by LDL. This effect of LDL was accompanied by a decrease in the synthesis of cyclic AMP induced by PGI2, but its efficacy depended on the relative concentrations of LDL and PGI2. PGI2 also enhanced the synthesis of cyclic GMP, but this was completely reversed by the presence of LDL. LDL did not remove inhibitory prostaglandins, e.g. E1, from their receptor sites. The lipoproteins also decreased cyclic AMP synthesis induced by forskolin, which has its effect on the GTP-sensitive protein or the catalytic unit of the adenylate cyclase enzyme complex. It is proposed that LDL may act on the enzyme catalytic unit via an inhibitory GTP-sensitive protein or by a separate mechanism which indirectly impedes the production of cyclic AMP.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6093767      PMCID: PMC1144279          DOI: 10.1042/bj2230189

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Relationships between membrane cholesterol, alpha-adrenergic receptors, and platelet function.

Authors:  P A Insel; P Nirenberg; J Turnbull; S J Shattil
Journal:  Biochemistry       Date:  1978-11-28       Impact factor: 3.162

2.  Identification of platelet receptors for prostaglandin I2 and D2.

Authors:  A I Schafer; B Cooper; D O'Hara; R I Handin
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

3.  Roles of cyclic nucleotides in platelet function.

Authors:  R J Haslam
Journal:  Ciba Found Symp       Date:  1975

Review 4.  Regulation of blood platelet function by cyclic nucleotides.

Authors:  R J Haslam; M M Davidson; T Davies; J A Lynham; M D McClenaghan
Journal:  Adv Cyclic Nucleotide Res       Date:  1978

5.  Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides.

Authors:  A L Steiner; C W Parker; D M Kipnis
Journal:  J Biol Chem       Date:  1972-02-25       Impact factor: 5.157

6.  The effect of lipoprotein fractions on adhesiveness and aggregation of blood platelets.

Authors:  R Farbiszewski; Z Skrzydlewski; K Worowski
Journal:  Thromb Diath Haemorrh       Date:  1969-02-28

7.  Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.

Authors:  J F Harper; G Brooker
Journal:  J Cyclic Nucleotide Res       Date:  1975

8.  Selective binding site for [3H]prostacyclin on platelets.

Authors:  A M Siegl; J B Smith; M J Silver; K C Nicolaou; D Ahern
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

9.  Modulation of human platelet adenylate cyclase by prostacyclin (PGX).

Authors:  R R Gorman; S Bunting; O V Miller
Journal:  Prostaglandins       Date:  1977-03

10.  Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.

Authors:  J E Tateson; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1977-03
View more
  5 in total

1.  Intracellular mechanisms in the activation of human platelets by low-density lipoproteins.

Authors:  H E Andrews; J W Aitken; D G Hassall; V O Skinner; K R Bruckdorfer
Journal:  Biochem J       Date:  1987-03-01       Impact factor: 3.857

2.  Lipoprotein receptor 'CK'--dependent signalling in human platelets.

Authors:  D Kaul; N Kochhar; J Singh
Journal:  Mol Cell Biochem       Date:  1995-10-18       Impact factor: 3.396

Review 3.  Platelet activation in normo- and hyperlipoproteinemias.

Authors:  J Nimpf; H Wurm; G M Kostner; T Kenner
Journal:  Basic Res Cardiol       Date:  1986 Sep-Oct       Impact factor: 17.165

4.  The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro.

Authors:  P M Bath
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  The actions of lovastatin on platelet function and platelet eicosanoid receptors in type II hypercholesterolaemia. A double-blind, placebo-controlled, prospective study.

Authors:  D Kaczmarek; T Hohlfeld; G Wambach; K Schrör
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.